Einde inhoudsopgave
Draft Common Frame of Reference
IV. C. — 8:105 Obligation to inform
Geldend
Geldend vanaf 01-01-2009
- Redactionele toelichting
De dag van de datum van afkondiging is gezet op 01. De datum van inwerkingtreding is de datum van afkondiging.
- Bronpublicatie:
01-01-2009, Internet 2009, ec.europa.eu (uitgifte: 01-01-2009, kamerstukken/regelingnummer: -)
- Inwerkingtreding
01-01-2009
- Bronpublicatie inwerkingtreding:
01-01-2009, Internet 2009, ec.europa.eu (uitgifte: 01-01-2009, kamerstukken/regelingnummer: -)
- Vakgebied(en)
Civiel recht algemeen (V)
EU-recht / Bijzondere onderwerpen
Internationaal privaatrecht / Algemeen
(1)
The treatment provider must, in order to give the patient a free choice regarding treatment, inform the patient about, in particular:
- (a)
the patient's existing state of health;
- (b)
the nature of the proposed treatment;
- (c)
the advantages of the proposed treatment;
- (d)
the risks of the proposed treatment;
- (e)
the alternatives to the proposed treatment, and their advantages and risks as compared to those of the proposed treatment; and
- (f)
the consequences of not having treatment.
(2)
The treatment provider must, in any case, inform the patient about any risk or alternative which might reasonably influence the patient's decision on whether to give consent to the proposed treatment or not. It is presumed that a risk might reasonably influence that decision if its materialisation would lead to serious detriment to the patient. Unless otherwise provided, the obligation to inform is subject to the provisions of Chapter 7 (Information and Advice).
(3)
The information must be provided in a way understandable to the patient.